The world pays attention to the successful case of the Ilyang Pharmaceutical’s leukemia treatment ‘Supect’
The successful case of the leukemia treatment, the domestically-developed new drug developed by Ilyang Pharmaceutical, ‘Supect,’ was introduced as the representative role model of the R&D and commercialization of a new innovative drug at the world’s largest bio international convention.
Ilyang P...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
